High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial
Alemany et al., The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(21)00545-2
https://c19early.org/alemany.html